Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression

Memy H. Hassan, Salama A. Salama, Hossam M.M. Arafa, Farid M.A. Hamada, Ayman Al-Hendy

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Context: Human uterine leiomyomas are very common smooth muscle cell tumors that occur in reproductive-age women and are the leading reason for performing hysterectomies. The present study was conducted to explore the potential mechanism behind the effects exerted by dominant-negative estrogen receptors (DNERs) delivered by adenovirus to leiomyoma cells to ascertain the utility of DNERs as a novel strategy for treatment of uterine fibroids. Objective and Methods: We investigated the ability of DNER to affect estrogen response element (ERE) activity induced by wild-type estrogen receptor (ER) by using the adenovirus ERE luciferase (Ad-ERE-luc) system in ELT3 cells and the effect of graded doses of DNER (10, 50, and 100 plaque-forming units/cell) on the expression of some selected genes controlling cultured human leiomyoma cell proliferation (cyclin D1, Cox2, PCNA, VEGF, and EGF), apoptosis (Bcl2 and Bax), estrogen metabolism (COMT), and extracellular matrix formation(MMP1) as well as progesterone receptors (A and B) were assessed using Western blot analysis. These genes are all regulated by estrogen and/or progesterone. Results: DNER has the ability to suppress the ERE luc activity induced by wild-type ER (P < 0.01) and significantly (P < 0.05) reverse the expression of all estrogen- and progesterone-regulated genes in this study. Conclusions: These results suggest that interruption of the estrogen signaling pathway using DNER results in modulation of both estrogen-and progesterone-regulated genes that control leiomyoma cell apoptosis, proliferation, extracellular matrix formation, progesterone receptors, and estrogen metabolism, which might account for the DNER mechanism of action.

Original languageEnglish (US)
Pages (from-to)3949-3957
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume92
Issue number10
DOIs
StatePublished - Jan 1 2007

Fingerprint

Leiomyoma
Adenoviridae
Gene expression
Estrogen Receptors
Progesterone
Estrogens
Genes
Gene Expression
Response Elements
Metabolism
Extracellular Matrix
Cell Proliferation
Smooth Muscle Tumor
Apoptosis
Cyclin D1
Proliferating Cell Nuclear Antigen
Cell proliferation
Progesterone Receptors
Luciferases
Hysterectomy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression. / Hassan, Memy H.; Salama, Salama A.; Arafa, Hossam M.M.; Hamada, Farid M.A.; Al-Hendy, Ayman.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 92, No. 10, 01.01.2007, p. 3949-3957.

Research output: Contribution to journalArticle

Hassan, Memy H. ; Salama, Salama A. ; Arafa, Hossam M.M. ; Hamada, Farid M.A. ; Al-Hendy, Ayman. / Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression. In: Journal of Clinical Endocrinology and Metabolism. 2007 ; Vol. 92, No. 10. pp. 3949-3957.
@article{ffa45dc41b9b498c9bd3261bb6bfd01e,
title = "Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression",
abstract = "Context: Human uterine leiomyomas are very common smooth muscle cell tumors that occur in reproductive-age women and are the leading reason for performing hysterectomies. The present study was conducted to explore the potential mechanism behind the effects exerted by dominant-negative estrogen receptors (DNERs) delivered by adenovirus to leiomyoma cells to ascertain the utility of DNERs as a novel strategy for treatment of uterine fibroids. Objective and Methods: We investigated the ability of DNER to affect estrogen response element (ERE) activity induced by wild-type estrogen receptor (ER) by using the adenovirus ERE luciferase (Ad-ERE-luc) system in ELT3 cells and the effect of graded doses of DNER (10, 50, and 100 plaque-forming units/cell) on the expression of some selected genes controlling cultured human leiomyoma cell proliferation (cyclin D1, Cox2, PCNA, VEGF, and EGF), apoptosis (Bcl2 and Bax), estrogen metabolism (COMT), and extracellular matrix formation(MMP1) as well as progesterone receptors (A and B) were assessed using Western blot analysis. These genes are all regulated by estrogen and/or progesterone. Results: DNER has the ability to suppress the ERE luc activity induced by wild-type ER (P < 0.01) and significantly (P < 0.05) reverse the expression of all estrogen- and progesterone-regulated genes in this study. Conclusions: These results suggest that interruption of the estrogen signaling pathway using DNER results in modulation of both estrogen-and progesterone-regulated genes that control leiomyoma cell apoptosis, proliferation, extracellular matrix formation, progesterone receptors, and estrogen metabolism, which might account for the DNER mechanism of action.",
author = "Hassan, {Memy H.} and Salama, {Salama A.} and Arafa, {Hossam M.M.} and Hamada, {Farid M.A.} and Ayman Al-Hendy",
year = "2007",
month = "1",
day = "1",
doi = "10.1210/jc.2007-0823",
language = "English (US)",
volume = "92",
pages = "3949--3957",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression

AU - Hassan, Memy H.

AU - Salama, Salama A.

AU - Arafa, Hossam M.M.

AU - Hamada, Farid M.A.

AU - Al-Hendy, Ayman

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Context: Human uterine leiomyomas are very common smooth muscle cell tumors that occur in reproductive-age women and are the leading reason for performing hysterectomies. The present study was conducted to explore the potential mechanism behind the effects exerted by dominant-negative estrogen receptors (DNERs) delivered by adenovirus to leiomyoma cells to ascertain the utility of DNERs as a novel strategy for treatment of uterine fibroids. Objective and Methods: We investigated the ability of DNER to affect estrogen response element (ERE) activity induced by wild-type estrogen receptor (ER) by using the adenovirus ERE luciferase (Ad-ERE-luc) system in ELT3 cells and the effect of graded doses of DNER (10, 50, and 100 plaque-forming units/cell) on the expression of some selected genes controlling cultured human leiomyoma cell proliferation (cyclin D1, Cox2, PCNA, VEGF, and EGF), apoptosis (Bcl2 and Bax), estrogen metabolism (COMT), and extracellular matrix formation(MMP1) as well as progesterone receptors (A and B) were assessed using Western blot analysis. These genes are all regulated by estrogen and/or progesterone. Results: DNER has the ability to suppress the ERE luc activity induced by wild-type ER (P < 0.01) and significantly (P < 0.05) reverse the expression of all estrogen- and progesterone-regulated genes in this study. Conclusions: These results suggest that interruption of the estrogen signaling pathway using DNER results in modulation of both estrogen-and progesterone-regulated genes that control leiomyoma cell apoptosis, proliferation, extracellular matrix formation, progesterone receptors, and estrogen metabolism, which might account for the DNER mechanism of action.

AB - Context: Human uterine leiomyomas are very common smooth muscle cell tumors that occur in reproductive-age women and are the leading reason for performing hysterectomies. The present study was conducted to explore the potential mechanism behind the effects exerted by dominant-negative estrogen receptors (DNERs) delivered by adenovirus to leiomyoma cells to ascertain the utility of DNERs as a novel strategy for treatment of uterine fibroids. Objective and Methods: We investigated the ability of DNER to affect estrogen response element (ERE) activity induced by wild-type estrogen receptor (ER) by using the adenovirus ERE luciferase (Ad-ERE-luc) system in ELT3 cells and the effect of graded doses of DNER (10, 50, and 100 plaque-forming units/cell) on the expression of some selected genes controlling cultured human leiomyoma cell proliferation (cyclin D1, Cox2, PCNA, VEGF, and EGF), apoptosis (Bcl2 and Bax), estrogen metabolism (COMT), and extracellular matrix formation(MMP1) as well as progesterone receptors (A and B) were assessed using Western blot analysis. These genes are all regulated by estrogen and/or progesterone. Results: DNER has the ability to suppress the ERE luc activity induced by wild-type ER (P < 0.01) and significantly (P < 0.05) reverse the expression of all estrogen- and progesterone-regulated genes in this study. Conclusions: These results suggest that interruption of the estrogen signaling pathway using DNER results in modulation of both estrogen-and progesterone-regulated genes that control leiomyoma cell apoptosis, proliferation, extracellular matrix formation, progesterone receptors, and estrogen metabolism, which might account for the DNER mechanism of action.

UR - http://www.scopus.com/inward/record.url?scp=35348950974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348950974&partnerID=8YFLogxK

U2 - 10.1210/jc.2007-0823

DO - 10.1210/jc.2007-0823

M3 - Article

C2 - 17635941

AN - SCOPUS:35348950974

VL - 92

SP - 3949

EP - 3957

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 10

ER -